Building the Future of

Cannabinoid Therapeutics

What We Do

Scopus BioPharma develops small molecule therapeutics leveraging world-class expertise in cannabinoid and cannabis research.

The endocannabinoid system is critical for maintaining overall human health by modulating key functions within the body. These include functions related to the immune, metabolic and nervous systems.

Synthetically-Produced Cannabinoids

Cannabinoids are naturally produced in the body and can also be derived from the cannabis plant or be synthetically produced. The most well-known and researched plant-derived and synthetically-produced cannabinoids are cannabidiol, or CBD, and tetrahydrocannabinol, or THC. Our prescription drug candidates use synthetically-produced cannabinoids, ensuring the highest level of quality control and consistency.

FDA Regulatory Pathway

We are pursuing FDA approval for our proprietary drug candidates, distinguishing them from increasingly commoditized cannabinoid products and enabling a clear pathway unencumbered by legal challenges associated with non-FDA approved products. We are working with leading cannabinoid research scientists at preeminent academic and research institutions.